Perspectives on Medicare Part D and Dual Eligibles: Key Informants’ Views from

Executive Summary

This report from Kaiser Family Foundation, based on interviews with providers, health officials and advocates in three states, discusses the rollout of the Medicare Part D prescription drug benefit and how it impacted individuals who are dually eligible for Medicare and Medicaid.

Perspectives on Medicare Part D and Dual Eligibles: Key Informants? Views From Three States
Apr 30, 2007
In 2006, low-income individuals receiving health coverage through both the Medicaid and Medicare programs, ?dual eligibles,? experienced a change in their prescription drug benefit when their Medicaid prescription coverage was replaced by the Medicare prescription drug program known as Medicare Part D. This study provides information on the ongoing successes and challenges that dual eligibles faced in the first eight months of Part D and how different state approaches may affect dual eligibles? ability to access prescription medications.

It was conducted in three states that adopted different approaches to helping dual eligibles with their Part D expenses: Connecticut, Washington and Florida. Connecticut offers substantial assistance, paying co-payments and providing a ?wraparound? to Part D that covers prescription drugs that are not on a dual eligible?s Part D plan formulary. Washington pays dual eligibles? co-payments but does not cover non-formulary medications. Florida offers neither type of assistance to dual eligibles. In addition, all three states cover certain drugs excluded from Medicare Part D through their Medicaid programs.

Text has been truncated. For full publication text, download document.

Related Content